Historical Valuation
Carter Bankshares Inc (CARE) is now in the Undervalued zone, suggesting that its current forward PE ratio of 6.79 is considered Undervalued compared with the five-year average of 9.79. The fair price of Carter Bankshares Inc (CARE) is between 20.16 to 38.36 according to relative valuation methord. Compared to the current price of 20.01 USD , Carter Bankshares Inc is Undervalued By 0.73%.
Relative Value
Fair Zone
20.16-38.36
Current Price：20.01
0.73%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Carter Bankshares Inc (CARE) has a current Price-to-Book (P/B) ratio of 1.05. Compared to its 3-year average P/B ratio of 0.98 , the current P/B ratio is approximately 7.19% higher. Relative to its 5-year average P/B ratio of 1.00, the current P/B ratio is about 5.74% higher. Carter Bankshares Inc (CARE) has a Forward Free Cash Flow (FCF) yield of approximately 7.25%. Compared to its 3-year average FCF yield of 11.13%, the current FCF yield is approximately -34.84% lower. Relative to its 5-year average FCF yield of 11.52% , the current FCF yield is about -37.04% lower.
P/B
Median3y
0.98
Median5y
1.00
FCF Yield
Median3y
11.13
Median5y
11.52
Competitors Valuation Multiple
AI Analysis for CARE
The average P/S ratio for CARE competitors is 2.60, providing a benchmark for relative valuation. Carter Bankshares Inc Corp (CARE.O) exhibits a P/S ratio of 2.52, which is -3.16% above the industry average. Given its robust revenue growth of 14.91%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CARE
1Y
3Y
5Y
Market capitalization of CARE increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CARE in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CARE currently overvalued or undervalued?
Carter Bankshares Inc (CARE) is now in the Undervalued zone, suggesting that its current forward PE ratio of 6.79 is considered Undervalued compared with the five-year average of 9.79. The fair price of Carter Bankshares Inc (CARE) is between 20.16 to 38.36 according to relative valuation methord. Compared to the current price of 20.01 USD , Carter Bankshares Inc is Undervalued By 0.73% .
What is Carter Bankshares Inc (CARE) fair value?
CARE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Carter Bankshares Inc (CARE) is between 20.16 to 38.36 according to relative valuation methord.
How does CARE's valuation metrics compare to the industry average?
The average P/S ratio for CARE's competitors is 2.60, providing a benchmark for relative valuation. Carter Bankshares Inc Corp (CARE) exhibits a P/S ratio of 2.52, which is -3.16% above the industry average. Given its robust revenue growth of 14.91%, this premium appears unsustainable.
What is the current P/B ratio for Carter Bankshares Inc (CARE) as of Jan 10 2026?
As of Jan 10 2026, Carter Bankshares Inc (CARE) has a P/B ratio of 1.05. This indicates that the market values CARE at 1.05 times its book value.
What is the current FCF Yield for Carter Bankshares Inc (CARE) as of Jan 10 2026?
As of Jan 10 2026, Carter Bankshares Inc (CARE) has a FCF Yield of 7.25%. This means that for every dollar of Carter Bankshares Inc’s market capitalization, the company generates 7.25 cents in free cash flow.
What is the current Forward P/E ratio for Carter Bankshares Inc (CARE) as of Jan 10 2026?
As of Jan 10 2026, Carter Bankshares Inc (CARE) has a Forward P/E ratio of 6.79. This means the market is willing to pay $6.79 for every dollar of Carter Bankshares Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Carter Bankshares Inc (CARE) as of Jan 10 2026?
As of Jan 10 2026, Carter Bankshares Inc (CARE) has a Forward P/S ratio of 2.52. This means the market is valuing CARE at $2.52 for every dollar of expected revenue over the next 12 months.